4.5 Review

Microglia in multiple sclerosis - pathogenesis and imaging

Related references

Note: Only part of the references are listed.
Review Clinical Neurology

Minocycline for the management of multiple sclerosis: repositioning potential, opportunities, and challenges

Prerna Chauhan et al.

Summary: The article discusses the potential of minocycline for the treatment of MS through repositioning, highlighting its immunomodulatory effects. Minocycline offers advantages such as a well-known safety profile, lower cost, wide availability, and oral formulation. The authors emphasize the need for well-designed randomized clinical trials to establish conclusive evidence on the safety and efficacy of minocycline in MS patients.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2021)

Article Clinical Neurology

Hydroxychloroquine for Primary Progressive Multiple Sclerosis

Marcus W. Koch et al.

Summary: The study found that treatment with the antimalarial drug hydroxychloroquine (HCQ) was associated with reduced disability worsening in people with primary progressive multiple sclerosis (PPMS), with only 8 out of 35 participants experiencing significant worsening in walking ability between 6 and 18 months. This suggests that HCQ may be a promising treatment option for PPMS, warranting further investigation in randomized controlled clinical trials.

ANNALS OF NEUROLOGY (2021)

Article Clinical Neurology

Long-term evolution of multiple sclerosis iron rim lesions in 7 T MRI

Assunta Dal-Bianco et al.

Summary: Iron rim lesions in multiple sclerosis patients signify a more severe disease course and propensity to develop progressive disease. Long-term follow-up reveals different dynamics of iron rim lesions in relapsing-remitting versus progressive disease, with potential implications for disease progression and brain damage.

BRAIN (2021)

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

Widespread Glial Activation in Primary Progressive Multiple Sclerosis Revealed by 18F-PBR06 PET A Clinically Feasible, Individualized Approach

Tarun Singhal et al.

Summary: This study used PET imaging to detect widespread glial activation in the brain of a patient with primary progressive multiple sclerosis, while MRI scans showed only a few small white matter lesions.

CLINICAL NUCLEAR MEDICINE (2021)

Review Biochemistry & Molecular Biology

Microglia: The Missing Link to Decipher and Therapeutically Control MS Progression?

Anastasia Geladaris et al.

Summary: Therapeutically controlling chronic progression in multiple sclerosis (MS) remains a major challenge, as the exact mechanisms causing progression are still unknown. Microglia may play a key role in driving disease progression of MS, providing a unique opportunity for the development of more effective therapeutics.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Clinical Neurology

Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial

Daniel S. Reich et al.

Summary: Tolebrutinib, an irreversible inhibitor of Bruton's tyrosine kinase, showed a dose-dependent reduction in new gadolinium-enhancing lesions in patients with relapsing multiple sclerosis. The 60 mg dose was the most efficacious and well tolerated among the tested doses. These findings provide a scientific rationale to pursue phase 3 clinical trials of tolebrutinib in patients with relapsing and progressive forms of multiple sclerosis.

LANCET NEUROLOGY (2021)

Review Clinical Neurology

Positron emission tomography in multiple sclerosis - straight to the target

Benedetta Bodini et al.

Summary: With significant progress in treating relapsing-remitting MS, the main challenge now is developing treatments to prevent or delay progressive forms of the disease. A deep understanding of the mechanisms behind neuro-axonal degeneration is crucial for developing therapies for progressive MS. PET imaging plays a key role in providing insights into the mechanisms of irreversible neuro-axonal damage in MS.

NATURE REVIEWS NEUROLOGY (2021)

Article Clinical Neurology

Longitudinal change in TSPO PET imaging in progressive multiple sclerosis

Yeona Kang et al.

Summary: The pilot study identified that innate immune activity may increase over time in patients with progressive MS, with a focus on PK11195 uptake in NAWM, cortex, thalamus, and putamen.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Individual Mapping of Innate Immune Cell Activation Is a Candidate Marker of Patient-Specific Trajectories of Worsening Disability in Multiple Sclerosis

Benedetta Bodini et al.

JOURNAL OF NUCLEAR MEDICINE (2020)

Article Clinical Neurology

Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging

Svetlana Bezukladova et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)

Article Clinical Neurology

Regional microglial activation in the substantia nigra is linked with fatigue in MS

Tarun Singhal et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)

Article Immunology

Novel Hexb-based tools for studying microglia in the CNS

Takahiro Masuda et al.

NATURE IMMUNOLOGY (2020)

Article Neurosciences

Single-cell mass cytometry reveals complex myeloid cell composition in active lesions of progressive multiple sclerosis

Chotima Boettcher et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)

Article Multidisciplinary Sciences

Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution

Takahiro Masuda et al.

NATURE (2019)

Article Medicine, General & Internal

Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis

Xavier Montalban et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Clinical Neurology

Natalizumab treatment reduces microglial activation in the white matter of the MS brain

Marcus Sucksdorff et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2019)

Article Clinical Neurology

Gray matter microglial activation in relapsing vs progressive MS A [F-18]PBR06-PET study

Tarun Singhal et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2019)

Article Medicine, Research & Experimental

Potential role of iron in repair of inflammatory demyelinating lesions

Nathanael J. Lee et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

Review Biotechnology & Applied Microbiology

Progressive multiple sclerosis: from pathophysiology to therapeutic strategies

Simon Faissner et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Review Clinical Neurology

When encephalitogenic T cells collaborate with microglia in multiple sclerosis

Yifei Dong et al.

NATURE REVIEWS NEUROLOGY (2019)

Article Clinical Neurology

Association of Chronic Active Multiple Sclerosis Lesions With Disability In Vivo

Martina Absinta et al.

JAMA NEUROLOGY (2019)

Article Biochemistry & Molecular Biology

Cross-Species Single-Cell Analysis Reveals Divergence of the Primate Microglia Program

Laufey Geirsdottir et al.

Article Immunology

The Role of Bruton's Tyrosine Kinase in Immune Cell Signaling and Systemic Autoimmunity

Jasper Rip et al.

CRITICAL REVIEWS IN IMMUNOLOGY (2018)

Review Medicine, General & Internal

Multiple Sclerosis

Daniel S. Reich et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Clinical Neurology

An updated histological classification system for multiple sclerosis lesions

Tanja Kuhlmann et al.

ACTA NEUROPATHOLOGICA (2017)

Article Endocrinology & Metabolism

Pro-inflammatory activation of primary microglia and macrophages increases 18 kDa translocator protein expression in rodents but not humans

David R. Owen et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2017)

Article Radiology, Nuclear Medicine & Medical Imaging

11C-PBR28 and 18F-PBR111 Detect White Matter Inflammatory Heterogeneity in Multiple Sclerosis

Gourab Datta et al.

JOURNAL OF NUCLEAR MEDICINE (2017)

Article Radiology, Nuclear Medicine & Medical Imaging

Evaluation of the Effect of Fingolimod Treatment on Microglial Activation Using Serial PET Imaging in Multiple Sclerosis

Marcus Sucksdorff et al.

JOURNAL OF NUCLEAR MEDICINE (2017)

Article Medicine, General & Internal

Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis

L. M. Metz et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Clinical Neurology

Reduction of PK11195 uptake observed in multiple sclerosis lesions after natalizumab initiation

Ulrike W. Kaunzner et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2017)

Article Clinical Neurology

Neuroinflammatory component of gray matter pathology in multiple sclerosis

Elena Herranz et al.

ANNALS OF NEUROLOGY (2016)

Review Immunology

The role of Bruton's tyrosine kinase in autoimmunity and implications for therapy

Leslie J. Crofford et al.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2016)

Article Clinical Neurology

Hydroxychloroquine reduces microglial activity and attenuates experimental autoimmune encephalomyelitis

Marcus W. Koch et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)

Article Endocrinology & Metabolism

Kinetic modeling without accounting for the vascular component impairs the quantification of [11C]PBR28 brain PET data

Gaia Rizzo et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2014)

Article Clinical Neurology

Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron

Lukas Haider et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)

Article Radiology, Nuclear Medicine & Medical Imaging

In Vivo Assessment of Brain White Matter Inflammation in Multiple Sclerosis with 18F-PBR111 PET

Alessandro Colasanti et al.

JOURNAL OF NUCLEAR MEDICINE (2014)

Article Radiology, Nuclear Medicine & Medical Imaging

In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand 11C-PK11195

Eero Rissanen et al.

JOURNAL OF NUCLEAR MEDICINE (2014)

Review Clinical Neurology

Iron in multiple sclerosis: roles in neurodegeneration and repair

Erin Stephenson et al.

NATURE REVIEWS NEUROLOGY (2014)

Article Clinical Neurology

Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons

Shailender Singh et al.

ACTA NEUROPATHOLOGICA (2013)

Article Clinical Neurology

Iron and Neurodegeneration in the Multiple Sclerosis Brain

Simon Hametner et al.

ANNALS OF NEUROLOGY (2013)

Article Cell Biology

Minocycline selectively inhibits M1 polarization of microglia

K. Kobayashi et al.

CELL DEATH & DISEASE (2013)

Article Biochemistry & Molecular Biology

A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis

Ivana Nikic et al.

NATURE MEDICINE (2011)

Article Medicine, General & Internal

Inflammatory Cortical Demyelination in Early Multiple Sclerosis

Claudia F. Lucchinetti et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Clinical Neurology

Activated Microglia Mediate Axoglial Disruption That Contributes to Axonal Injury in Multiple Sclerosis

Owain W. Howell et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2010)

Article Multidisciplinary Sciences

Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo

A Nimmerjahn et al.

SCIENCE (2005)

Article Clinical Neurology

PET visualization of microglia in multiple sclerosis patients using [11C]PK11195

JC Debruyne et al.

EUROPEAN JOURNAL OF NEUROLOGY (2003)

Article Clinical Neurology

Immunopathology of secondary-progressive multiple sclerosis

JW Prineas et al.

ANNALS OF NEUROLOGY (2001)

Review Neurosciences

Metalloproteinases in biology and pathology of the nervous system

VW Yong et al.

NATURE REVIEWS NEUROSCIENCE (2001)